Middle East and Africa Biomaterials Market Introduction and Overview
According to SPER Market Research, the Middle East and Africa Biomaterials Market is estimated to reach USD 23.24 billion by 2033 with a CAGR of 12.89%.
The report includes an in-depth analysis of the Middle East and Africa Biomaterials Market, including market size and trends, product mix, distribution channels, and supplier analysis. Biomaterials are a broad class of materials, either synthetic or natural, that are designed to interact with biological systems in a therapeutic, medicinal, or diagnostic capacity. In the fields of medicine and healthcare, these materials are essential because they help create cutting-edge tools, implants, and medication delivery systems. Because of their biocompatibility and smooth integration with biological tissues, natural biomaterials are highly prized. They are frequently derived from sources like collagen, hyaluronic acid, or silk. On the other hand, synthetic biomaterials, such as metals, polymers, and ceramics, are made to have particular chemical and physical characteristics that guarantee their durability, flexibility, and resistance to deterioration. Biomaterials are used in a wide range of applications, including tissue engineering, medication delivery systems, cardiovascular devices, and orthopedic implants including joint replacements.
Market Opportunities and Challenges
Opportunities: The primary reason for the increased usage of biomaterials is the ongoing medical technology research aimed at ensuring the effective operation of medical implants. The Middle East and African biomaterials market is expanding because to many causes include the availability of innovative technologies like hydrogen scaffolding and decellularized dermal matrixes for grafting, as well as an increase in government financing. Additionally, as the number of elderly patients rises, there is a growing need for biomaterials in the fields of cardiology, neurology, wound healing, and plastic surgery. In addition, it will help the market expand at a robust rate over the duration of the forecast.
Challenges: Numerous challenges that hinder the biomaterials market's expansion and advancement are there. Complying with regulations and other obligations is a major task. Tight regulatory requirements for biomaterials used in implants and medical devices guarantee their efficacy and safety, which drives up costs for producers and prolongs approval procedures. The intricacy of biomaterials itself presents another difficulty. Time-consuming and expensive research and development work is frequently needed to create biomaterials with the appropriate qualities, such as functioning, durability, and biocompatibility.
Market Competitive Landscape
The Biomaterials Market in Middle East and Africa is highly fragmented. Some of the market key players are BASF SE, Bayer AG, Berkeley Advanced Biomaterials, CAM Bioceramics BV, Carpenter Technology Corporation, Collagen Matrix, Inc., Covalon Technologies Ltd., Corbion N.V., Evonik Industries AG, Royal DSM, Invibio Ltd., Zimmer Biomet Holdings, Inc., Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Material Type, By Application
|
| Regions covered | Eastern, Western, Southern, Northern
|
| Companies Covered | BASF SE, Bayer AG, Berkeley Advanced Biomaterials, CAM Bioceramics BV, Carpenter Technology Corporation, Collagen Matrix, Inc., Covalon Technologies Ltd., Corbion N.V., Evonik Industries AG, Royal DSM, Invibio Ltd., Zimmer Biomet Holdings, Inc., Others.
|
COVID-19 Impact on Middle East and Africa Biomaterials Market
The biomaterials market in the Middle East and Africa was greatly affected by the COVID-19 epidemic, albeit with differences depending on the region. As a result of border closures, travel restrictions, and lockdowns, the market first faced supply chain disruptions that caused delays in the delivery of both raw materials and completed goods. Biomaterials utilized in orthopedic implants, dental operations, and tissue engineering applications were in high demand as a result of the postponement or cancellation of elective medical procedures in order to prioritize resources for COVID-19 patients. Still, the market saw a slow rebound as healthcare systems made adjustments and started performing elective surgery again.
Key Target Audience:
- Healthcare Industry
- Medical Device Manufacturers
- Pharmaceutical Companies
- Research Institutions and Laboratories
- Academic Institutions
- Regulatory Bodies and Government Agencies
- Biotechnology Companies
Our in-depth analysis of the Middle East and Africa Biomaterials Market includes the following segments:
|
By Material Type: |
Ceramic
Metallic
Polymer
Natural
|
|
By Application: |
Orthopedic
Dental
Cardiovascular
Plastic Surgery
Wound Healing
Ophthalmology
Tissue engineering
Neurological
Others
|
Key Topics Covered in the Report:
- Middle East and Africa Biomaterials Market Size (FY’2024-FY’2033)
- Overview of Middle East and Africa Biomaterials Market
- Segmentation of Middle East and Africa Biomaterials Market By Application (Orthopedic, Dental, Cardiovascular, Plastic Surgery, Wound Healing, Ophthalmology, Tissue engineering, Neurological, Others)
- Expansion Analysis of Middle East and Africa Biomaterials Market
- Problems and Obstacles in Middle East and Africa Biomaterials Market
- Competitive Landscape in the Middle East and Africa Biomaterials Market
- Impact of COVID-19 and Demonetization on Middle East and Africa Biomaterials Market
- Details on Current Investment in Middle East and Africa Biomaterials Market
- Competitive Analysis of Middle East and Africa Biomaterials Market
- Prominent Players in the Middle East and Africa Biomaterials Market
- SWOT Analysis of Middle East and Africa Biomaterials Market
- Middle East and Africa Biomaterials Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Middle East and Africa Biomaterials Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Middle East and Africa Biomaterials Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Middle East and Africa Biomaterials Market
7. Middle East and Africa Biomaterials Market, By Material Type (USD Million) 2020-2033
7.1. Middle East and Africa Biomaterials Market Size, Share and Forecast, By Material Type, 2020-2026
7.2. Middle East and Africa Biomaterials Market Size, Share and Forecast, By Material Type, 2027-2033
7.3. Ceramic
7.4. Metallic
7.5. Polymer
7.6. Natural
8. Middle East and Africa Biomaterials Market, By Application (USD Million) 2020-2033
8.1. Middle East and Africa Biomaterials Market Size, Share and Forecast, By Application, 2020-2026
8.2. Middle East and Africa Biomaterials Market Size, Share and Forecast, By Application, 2027-2033
8.3. Orthopedic
8.4. Dental
8.5. Cardiovascular
8.6. Plastic Surgery
8.7. Wound Healing
8.8. Ophthalmology
8.9. Tissue engineering
8.10. Neurological
8.11. Others
9. Middle East and Africa Biomaterials Market Forecast, 2020-2033 (USD Million)
9.1. Middle East and Africa Biomaterials Market Size and Market Share
10. Middle East and Africa Biomaterials Market, By Region, 2020-2033 (USD Million)
10.1. Middle East and Africa Biomaterials Market Size and Market Share By Region (2020-2026)
10.2. Middle East and Africa Biomaterials Market Size and Market Share By Region (2027-2033)
10.3. Southern
10.4. Northern
10.5. Eastern
10.6. Western
11. Company Profile
11.1. BASF SE
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Bayer AG
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. Berkeley Advanced Biomaterials
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. CAM Bioceramics BV
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Carpenter Technology Corporation
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Collagen Matrix, Inc.
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. Covalon Technologies Ltd.
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Corbion N.V.
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Evonik Industries AG
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Royal DSM
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Invibio Ltd.
11.11.1. Company details
11.11.2. Financial outlook
11.11.3. Product summary
11.11.4. Recent developments
11.12. Zimmer Biomet Holdings, Inc.
11.12.1. Company details
11.12.2. Financial outlook
11.12.3. Product summary
11.12.4. Recent developments
11.13. Others
12. List of Abbreviations
13. Reference Links
14. Conclusion
15. Research Scope